Musculoskeletal Flashcards
Rheumatoid arthritis (RA)
a chronic systemic inflammatory autoimmune disorder that primarily affect the joints but may also manifest with extra articular features e.g. rheumatoid nodules or pulmonary fibrosis
Epidemiology of rheumatoid arthritis (RA)
affects ~1% of the population
more commonly seen in women (2-4x)
peak age of onset 30-50 yrs
Risk factors for rheumatoid arthritis (RA)
smoking*
genetic predisposition (HLA-DR4, HLA-DR1)
obesity
Family history of RA
Arthritic presentation of rheumatoid arthritis (RA)
Polyarthritis:
symmetrical pain, swelling, heat, stiffness (stiffness worse in morning lasting >30min) of affected joint
usually affects metacarpopahryngeal (MCP) / proximal interphalangeal (PIP) / metatarsopharyngeal (MTP) joints, later progressing to affect larger joints
Joint deformities (later in disease):
swan neck deformity (PIP hyperextension, DIP flexion)
boutonniere ferocity (PIP flexion, DIP hyperextension)
Z deformity of thumb (hyperextension of interphalangeal joint, fixed flexion of MCP)
ulnar deviation of fingers
atlantoaxial subluxation
piano key sign (dorsal subluxation of ulna)
NB Distal interphalangeal joints (DIP) are really affected, DIP involvement usually indicates psoriatic arthritis
extra articular manifestations of rheumatoid arthritis (RA)
Rheumatoid nodules:
skin (non tender firm swellings)
lungs (bilateral & peripheral)
Lungs:
pleuritic chest pain, fibrosis
Eyes:
keratoconjunctivitis sicca (most common)
episcleritis, scleritis
anaemia carpal tunnel syndrome purpura vasculitic ulcers Raynauds phenomenon (recurrent vasospasm of fingers & toes)
Examination findings for rheumatoid arthritis (RA)
compression test (Gaenslen squeeze test) = painful compression of MCP joint
may present as painful handshake
Investigation findings for rheumatoid arthritis (RA)
ESR/CRP (↑)
FBC (normochromic normocytic anaemia + thrombocytosis)
LFTs (↑ALP, ↑ gamma GT)
Rheumatoid factor (+ve in 70% of pts)
Antinuclear antibody - ANA (+ve in 30% of pts)
anti-cyclic citrullinated peptide (anti-CCP) antibody (+ve in 70% of pts)
synovial fluid analysis (cloudy, yellow appearance, leucocytosis (WBC = 5000-50,000) ↑proteins)
X-rays (early = loss of joint space, juxta-articular osteoporosis, soft tissue swelling, late= periarticular erosions, subluxation, bon/cartilage erosion, suchondral cysts)
USS (synovitis)
Imagine findings for rheumatoid arthritis (RA)
X-rays:
early = loss of joint space, juxta-articular osteoporosis, soft tissue swelling
late= periarticular erosions, subluxation, bon/cartilage erosion, suchondral cysts
USS; synovitis
Disease severity score for rheumatoid arthritis (RA)
DAS28
Diagnostic criteria for rheumatoid arthritis (RA)
≥6 points is considered RA
Joint distribution: 1 large joint = 0 points 2-10 large joints = 1 point 1-3 small joints = 2 points 4-10 small joints = 3 points >10 joints (at least 1 small) = 5 points
Serology:
negative RF & anti-CCP = 0 points
low positive RF or anti-CCP = 2 points
high positive RF or anti-CCP = 3 points
Duration:
< 6 weeks = 0 points
> 6 weeks - 1 point
Acute phase reactants:
normal CRP/ESR = 0 points
↑ CRP/ESR = 1 point
Antibodies for rheumatoid arthritis (RA)
Rheumatoid factor (+ve in 70% of pts)
Antinuclear antibody - ANA (+ve in 30% of pts)
anti-cyclic citrullinated peptide (anti-CCP) antibody (+ve in 70% of pts)
anti-CCP is most specific
Non drug management of rheumatoid arthritis (RA)
MDT approach
exercise
pain clinics
Pharmacological management rheumatoid arthritis (RA)
Symptomatic treatment:
NSAIDs (e.g. ibuprofen, naproxen) or COX-2 inhibitors (e.g. celecoxib) + a PPI (e.g. lansoprazole)
Corticosteroids:
for short-term flare up management and short term bridging treatment when starting DMARDs
DMARDs:
1st line: Methotrexate + corticosteroids to bridge treatment
other options: hydroxychloroquine, sulfalazine, leflunomide
Biologicals:
if moderate/severe disease after >3 months of DMARDs
e.g. rituximab, TNF-inhibitors (e.g. adalimumab, etanercept)
Methotrexate
given once a week orally, usually co-precribed with folic acid
monitoring: FBC / LFTs / renal function
Side effects: myelosuppresion, liver cirrhosis, pneumonitis, teratogenic (i.e. do not get pregnant )
NB avoid NSAIDs on day of methotrexate dose
Hydroxychloroquine
no regular blood test required
considered safe in pregnancy
side effects: retinopathy (bullseye retinopathy), corneal deposits
Sulfalazine
safe in pregnancy
monitoring: FBC / LFTs / renal function
side effects: interstitial lung disease, oligospermia, Heinz body anaemia, rash
Leflunomide
monitoring: FBC / LFTs / renal function / BP&weight
side effects: cushingoid features, osteoporosis, impaired glucose tolerance, HTN
Felty’s syndrome
complication of rheumatoid arthritis
triad of RA, splenomegaly, neutropenia
only seen in seropositive RA
treat firstling with methotrexate
Caplan syndrome
complication of rheumatoid arthritis in combination with pneumoconiosis (e.g. asbestosis/silicosis)
rapid development of basilar nodules & obstruction of ventilation
usually seen with coal dust exposure
Occular complications of rheumatoid arthritis
dry eye syndrome (keratoconjunctivitis sicca)
episcleritis
scleritis
steroid induced cataracts
Other complications of rheumatoid arthritis
osteoporosis respiratory (bronchiolitis, pulmonary fibrosis, pleural effusion, pulmonary nodules, bronchiolitis) raynauds phenomenon depression amyloidosis carpal tunnel syndrome vasculitis & vasculitic ulcers atlanta axial subluxation (due to inflammatory destruction of ligaments )
Raynaud phenomenon
characterised by paroxysmal vasospasm & subsequent vasodilatory chain of events affecting peripheral arterioles usually in the hands & feet
typically presents in young women
triggers: cold, emotional stress
Aetiology of raynauds
primary = raynauds disease:
onset usually <30y/o
secondary = raynauds phenomenon
may be related to RA, SLE, scleroderma, meds (COCP)
usually later onset in RA/SLE, >40 y/o
Presentation of Raynauds
usually symmetrical ischaemic phase (white) = vasoconstriction → hypoxic phase (blue) → hyperaemic phase (red) = vasodilation affects fingers & toes lasts 15-30 min after removing trigger no tissue damage / ulceration in primary